CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
that suggests the potential for clinical benefit of COVID-19 patients with controlled cancers.1. Treat Infection of Multiple Gene M-...
Early Phase 1
North Bethesda, Maryland, United States
The main purpose of this study is to test an investigational drug known as VYD2311, which is being developed to lower the risk of getting COVID...
Phase 3
Silver Spring, Maryland, United States and 19 other locations
COVID-19 is a systemic inflammatory disease involving many organs including the lungs, vascular system liver and myocardium that le-...
Baltimore, Maryland, United States
The purpose of this trial is to assess the safety and relative efficacy of CVXGA (CVXGA50), a KP.2 containing vaccine, compared to COMIRNATY® (COVID...
Phase 2
Washington D.C., District of Columbia, United States and 54 other locations
Performance of the LumiraDx SARS-CoV-2 Ag assay will be assessed by comparison to a reference method.
Millersville, Maryland, United States and 6 other locations
mild to severe acute respiratory distress syndrome (ARDS) due to COVID-19 resultant from 2019-nCoV coronavirus infection, or result...
Phase 1
Baltimore, Maryland, United States and 2 other locations
vaccine for the prevention of symptomatic Coronavirus Disease 2019 (COVID-19).In order to represent a more recently circulating SAR...
Phase 2
Washington D.C., District of Columbia, United States and 144 other locations
This is a Phase 4, post-market US study, evaluating the efficacy and safety of a single dose of the NVX-CoV2705 Omicron JN.1 COVID-19...
Phase 4
Rockville, Maryland, United States and 98 other locations
seek to enroll immunocompromised patients with Lower Tract parainfluenza infection.It also contains a sub-study to enroll patients with severe COVID...
Phase 3
Baltimore, Maryland, United States and 66 other locations
The purpose of the study is to evaluate whether ibuzatrelvir is effective and safe in adults and adolescents with COVID-19 who do n...
Phase 3
Washington D.C., District of Columbia, United States and 131 other locations
Clinical trials
Research sites
Resources
Legal